BIG PHARMA EARNINGS WATCH: ELI LILLY, GLAXOSMITHKLINE AND ASTRAZENECA

Another Blockbuster Quarter for Profits as Big Pharma Maintains Business-as-Usual Approach to Price Gouging Americans Eli Lilly, GlaxoSmithKline and AstraZeneca rounded out earnings calls for Big

11-14-2023 Read More

SECOND OPINION: NUMBER OF CANCER DRUGS IN DEVELOPMENT CLIMBS DESPITE PHRMA CLAIM DRUG PRICING SOLUTIONS WOULD UNDERMINE ONCOLOGY INNOVATION

PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing Larger Oops. Big Pharma accidentally helped debunk one of the myths perpetuated by the pharmaceutical industry this week

11-10-2023 Read More

CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM

Commission Targets More Than 100 Patents on Brand Name Products Listed in the U.S. Food and Drug Administration’s Orange Book For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

11-7-2023 Read More

BIG PHARMA EARNINGS WATCH: ABBVIE AND AMGEN

Another Series of Strong Earnings Reports For Brand Name Giants Fueled by Egregious Price Increases This week, Big Pharma giant AbbVie and Amgen both held earnings calls for the third quarter where

11-3-2023 Read More

ICYMI: CSRxP JOINS MORE THAN 50 ORGANIZATIONS CALLING ON THE U.S. SENATE TO PASS BIPARTISAN SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Broad-based Coalition of Advocates, Including AARP and Patients for Affordable Drugs Now, Encourage Lawmakers to Boost Competition, Hold Big Pharma Accountable to Lower Drug Prices In case you

11-2-2023 Read More

BIG PHARMA WATCH: BIG PHARMA HIKED PRICES ON MORE THAN 100 MEDICATIONS ABOVE THE RATE OF INFLATION THIS SUMMER

New Analysis Finds Drug Companies Continue to Price-Gouge American Patients, Increase Prices on Brand Name Drugs Used to Treat Serious Conditions An analysis released Wednesday by the Center for

11-2-2023 Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK AND BRISTOL MYERS SQUIBB

More Q3 Earnings From Big Pharma Giants Top Wall Street Expectations Following Price Hikes Earlier In Year As more Big Pharma giants announce third quarter earnings for 2023

10-27-2023 Read More

BIG PHARMA WATCH: ONCOLOGISTS WHO RECEIVED BIG PHARMA KICKBACKS WERE MORE LIKELY TO PRESCRIBE HIGHER PRICED AND LESS EFFECTIVE DRUGS

Research Exposes How Big Pharma’s Self-Serving Kickbacks Increase Costs and Can Negatively Impact Outcomes for Patients A new paper published by BMJ found that oncologists who received kickback

10-27-2023 Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Big Pharma Giant Kicks Off Q3 Earnings After Hiking Prices More Than 40 Times This Year This week, brand name drug giant Johnson & Johnson kicked off the first round of Big Pharma earnings calls

10-20-2023 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.